Melissa Fleury,Adam D. Hughes,Anne-Marie Beausoleil,Erik Fenster,Venkat R. Thalladi,Miroslav Rapta
申请号：
US16207501
公开号：
US20190269659A1
申请日:
2018.12.03
申请国别(地区):
US
年份:
2019
代理人:
摘要：
In one aspect, the invention relates to a compound of the structure:or a pharmaceutically acceptable salt thereof, and a crystalline form of this compound, having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising this compound； methods of using this compound； and processes for preparing this compound.
